Follow the Hikal Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are quoted on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Hikal Limited has recorded 10 insider filings. Market capitalisation: €23.4bn. The latest transaction was disclosed on 18 February 2026 (Purchase). Among the most active insiders: Ashok Vishwanath Hiremath. Every trade is openly available.
10
Insider Decl.
0
Thresholds
€2m
8 ops.
Buy Volume
€577,913
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Hikal Limited Strong Buy (bullish), based on 1 analysts. Average price target: ₹300.00.
19Σ signal
Buys €2m€577,913 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,144 of 26,213 companies
39.0
score / 100
Value
40
Quality
38
FCF yld6.6%
Earn yld-2.1%
EV/EBITDA20.5x
ROE·
Gross mgn55%
Net mgn-2.9%
Debt/EBITDA4.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.